Pfizer to file for emergency authorization for its Covid-19 pill
In an anticipated move, Pfizer (PFE) CEO Albert Bourla said the company plans ask the U.S. Food and Drug Administration on Tuesday to authorize emergency use of its antiviral pill for combating Covid-19.
Bourla announced the company’s intention to file the application earlier than expected at the 2021 STAT Summit. The step comes shortly after the company reported its pill, called Paxlovid, reduced hospitalizations by 89% among patients who started within three days of symptoms and also prevented deaths in a large, randomized study. The disclosure followed news from Merck (MRK) that its own pill reduced hospitalizations by 50%, although data was not shared on patients treated within three days of symptoms.
Read Original Article: Pfizer to file for emergency authorization for its Covid-19 pill »
